Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-018347)

Filing Details

Accession Number:: 0001209191-13-018347
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-26 13:03:50
Reporting Period:: 2013-03-26

Filing Date:: 2013-03-26
Accepted Time:: 2013-03-26 13:03:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Lilly Eli & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1463321	Susan Mahony	Lilly Corporate Center Indianapolis IN 46285	Svp & Pres., Lilly Oncology	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-03-26	5,000	$56.00	47,380	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,512	Indirect	401(k)
Common Stock	1,502	Indirect	401(k) - by husband
Common Stock	6,218	Indirect	by husband

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2013.
Reporting person disclaims beneficial ownership of these shares.